Literature DB >> 29256126

Pain Medications and Male Reproduction.

Erma Z Drobnis1, Ajay K Nangia2.   

Abstract

The increasing use of opioid medications has become a crisis in developed countries. The profound negative effects of opioids on male reproduction are well known, but this topic is absent from the current conversations about these medications. In the fertility clinic, a significant proportion of our patients are using opioids for pain management, and the options for these men are unclear. Opioids exert their negative effects by a variety of mechanisms. At high doses, testosterone levels fall significantly and hypogonadism is seen. In part, this results from increased prolactin and inhibition of gonadotropin production/secretion by the pituitary. However, negative effects on the testis are seen even in the absence of decreased androgen levels. As we review in this chapter, Leydig and germ cells produce endogenous opioids, and receptors for these substances are present throughout the testis. For example, endogenous opioids produced by Leydig and germ cells provide paracrine inhibition at Sertoli cell receptors, decreasing the production of androgen binding protein, which is required for intra-testis transport of androgens. Morphine also increases the expression of aromatase in the brain and testis and acts directly on the testis and germ cells to decrease testicular function. Exogenous opioids in men reduce semen quality, including increased DNA fragmentation. All opioids have these effects, but less damage is caused by lower doses, shorter-acting opioids, and by some drugs with mixed receptor activity, such as tramadol and tapentadol. The non-steroid anti-inflammatory drugs (NSAIDS) have much less effect on the male reproductive system, although there is a paucity of human studies. Paracetamol has been shown to cause sperm abnormalities, including DNA fragmentation, and to increase time to pregnancy and may prove to be of greater concern. In rodents, paracetamol has negative impacts on seminiferous tubule histology and fertility. Robust, well-designed studies in humans are needed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29256126     DOI: 10.1007/978-3-319-69535-8_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Evaluation and Management of Chronic Scrotal Content Pain-A Common Yet Poorly Understood Condition.

Authors:  Matthew J Ziegelmann; M Ryan Farrell; Laurence A Levine
Journal:  Rev Urol       Date:  2019

Review 2.  Andrology: Ibuprofen and hypogonadism - bench to bedside to misinterpreted hype?

Authors:  Ajay K Nangia; Derek Jensen
Journal:  Nat Rev Urol       Date:  2018-03-06       Impact factor: 14.432

Review 3.  Tapentadol: an overview of the safety profile.

Authors:  Enrico Polati; Pier Luigi Canonico; Vittorio Schweiger; Massimo Collino
Journal:  J Pain Res       Date:  2019-05-16       Impact factor: 3.133

4.  Proposed Key Characteristics of Male Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Evidence in Human Health Hazard Assessments.

Authors:  Xabier Arzuaga; Martyn T Smith; Catherine F Gibbons; Niels E Skakkebæk; Erin E Yost; Brandiese E J Beverly; Andrew K Hotchkiss; Russ Hauser; Rodrigo L Pagani; Steven M Schrader; Lauren Zeise; Gail S Prins
Journal:  Environ Health Perspect       Date:  2019-06-14       Impact factor: 9.031

Review 5.  Reprotoxic Impact of Environment, Diet, and Behavior.

Authors:  Alessandra Gallo
Journal:  Int J Environ Res Public Health       Date:  2022-01-24       Impact factor: 3.390

6.  Comparative Histological Study on the Effect of Tramadol Abuse on the Testis of Juvenile and Adult Male Albino Mice.

Authors:  Amal T Abou Elghait; Tarek M Mostafa; Fatma K Gameaa; Gamal K Mohammed; Fatma Y Meligy; Manal M Sayed
Journal:  Anat Cell Biol       Date:  2022-08-26

7.  Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies.

Authors:  Mutyala Satish; Sandhya Kumari; Waghela Deeksha; Suman Abhishek; Kulhar Nitin; Satish Kumar Adiga; Padmaraj Hegde; Jagadeesh Prasad Dasappa; Guruprasad Kalthur; Eerappa Rajakumara
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.